Home LiteratureArticle Details
PMID: 6222136 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.

The Journal of experimental medicine ·Vol. 157 ·No. 6 ·1983-06-01 ·Pages 1971-80

Pangburn MK, Schreiber RD, Trombold JS, Müller-Eberhard HJ

Abstract

Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) contained a subpopulation that lacked membrane-associated Factor H-like activity present on normal human erythrocytes. Initial deposition of C3b on the erythrocytes was effected using a fluid phase C3 convertase. The cells were then treated with fluorescein-labeled C3 and the cell-bound C3 convertase. Analysis utilizing the fluorescence-activated cell sorter revealed two distinct cell populations, one of which was highly fluorescent, indicating a large number of C3b molecules per cell. Only this population (43%) was susceptible to lysis (44%) when exposed to acidified serum before C3b deposition. The less fluorescent population resembled normal human erythrocytes and was not affected by prior treatment with acidified serum. Since C3b deposition occurred almost exclusively on the complement-sensitive cells in the PNH erythrocyte population, these cells could be examined for the Factor H-like regulatory activities without prior isolation. These functions include enhancement of inactivation of erythrocyte-bound C3b by Factor I and acceleration of the decay of erythrocyte-bound C3 convertase, C3b,Bb. It was found that C3b on PNH erythrocytes was 100-fold less susceptible to inactivation by Factor I than C3b on normal human erythrocytes. The half-life at 22 degrees C of C3b,Bb on PNH erythrocytes was threefold greater than on normal human erythrocytes and similar to that of the enzyme bound to particles that do not possess Factor H-like activity. These observations suggest that the abnormal susceptibility of PNH erythrocytes to lysis by complement is due to a functional deficiency in one or more of the Factor H-like proteins present on normal human erythrocytes.

MeSH Terms
Complement C3/metabolism Complement C3-C5 Convertases/blood Complement C3b/metabolism Complement C3b Inactivator Proteins/deficiency Complement Factor H Complement Factor I Endopeptidases/pharmacology Erythrocyte Membrane/metabolism Erythrocytes/metabolism Hemoglobinuria, Paroxysmal/blood Humans Receptors, Complement/metabolism Receptors, Complement 3b
Chemicals
CFH protein, human Complement C3 Complement C3b Inactivator Proteins Receptors, Complement Receptors, Complement 3b Complement C3b Complement Factor H Endopeptidases Complement C3-C5 Convertases Complement Factor I
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pangburn M K
Schreiber R D
Trombold J S
Müller-Eberhard H J
References (32)
32 references, click to expand
  1. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.
    Immunochemistry. 1969 May;6(3):391-403 PMID: 5786933
  2. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.
    Immunochemistry. 1969 May;6(3):405-19 PMID: 5786934
  3. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    J Immunol. 1969 Nov;103(5):944-52 PMID: 4981797
  4. Lysis of erythrocytes by complement in the absence of antibody.
    J Exp Med. 1970 Nov;132(5):898-915 PMID: 5470509
  5. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.
    N Engl J Med. 1972 Jan 27;286(4):180-4 PMID: 5007123
  6. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  7. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    J Clin Invest. 1973 May;52(5):1129-37 PMID: 4700488
  8. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
    J Exp Med. 1975 Sep 1;142(3):760-72 PMID: 1165475
  9. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    J Exp Med. 1977 Jul 1;146(1):257-70 PMID: 301546
  10. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20 PMID: 276881
  11. Paroxysmal nocturnal haemoglobinuria in aplastic anaemia.
    Clin Haematol. 1978 Oct;7(3):541-53 PMID: 363327
  12. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    J Immunol. 1979 Aug;123(2):529-34 PMID: 458145
  13. Studies of the molecular mechanisms of C3b inactivation and a simplified assay of beta 1H and the C3b inactivator (C3bINA).
    J Immunol. 1979 Sep;123(3):1195-204 PMID: 469245
  14. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
  15. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  16. Molecular biology and chemistry of the alternative pathway of complement.
    Adv Immunol. 1980;29:1-53 PMID: 6158260
  17. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    J Exp Med. 1980 Oct 1;152(4):1102-14 PMID: 6903192
  18. Large scale isolation of functionally active components of the human complement system.
    J Biol Chem. 1981 Apr 25;256(8):3995-4006 PMID: 6783652
  19. Complement receptor is an inhibitor of the complement cascade.
    J Exp Med. 1981 May 1;153(5):1138-50 PMID: 6910481
  20. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    J Immunol. 1981 Oct;127(4):1348-54 PMID: 7276561
  21. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    J Exp Med. 1981 Sep 1;154(3):856-67 PMID: 6912277
  22. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
    J Clin Invest. 1982 Feb;69(2):337-46 PMID: 6915939
  23. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate.
    J Biol Chem. 1982 Jul 25;257(14):8292-9 PMID: 6919543
  24. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    J Immunol. 1982 Jul;129(1):184-9 PMID: 6211481
  25. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    N Engl J Med. 1982 Oct 14;307(16):981-6 PMID: 7110302
  26. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells.
    Clin Exp Immunol. 1982 Jun;48(3):715-25 PMID: 7116690
  27. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.
    J Immunol. 1982 Nov;129(5):2051-60 PMID: 6214588
  28. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Proc Natl Acad Sci U S A. 1982 Aug;79(16):5047-51 PMID: 6214790
  29. On the lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by complement: dual role of C3b.
    Blut. 1982 Oct;45(4):249-59 PMID: 7126880
  30. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Clin Exp Immunol. 1982 Oct;50(1):209-14 PMID: 6216999
  31. Activation of complement via the alternative pathway.
    Fed Proc. 1983 Jan;42(1):139-43 PMID: 6217084
  32. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    J Clin Invest. 1956 May;35(5):453-7 PMID: 13319478
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1983-06-01
Pages
1971-80
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2187048
Subset
IM
Grants
NIAID NIH HHS · AI 17354 · United States
NCI NIH HHS · CA 27490 · United States
NHLBI NIH HHS · HL 07195 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com